Lasseter K C, Levey G S, Palmer R F, McCarthy J S
J Clin Invest. 1972 Sep;51(9):2429-34. doi: 10.1172/JCI107056.
Long-term clinical studies have associated tolbutamide therapy with an increased incidence of cardiovascular deaths. The effects of this and other sulfonylurea drugs on contractility and rate of isolated rabbit atria, automaticity of isolated dog Purkinje fibers, and adenyl cyclase activity in particulate preparations of rabbit and human hearts were studied. At concentrations that are attained clinically, tolbutamide (10 mg/100 ml) increased contractility of driven rabbit atria to 124+/-5% of control, acetohexamide (3.9 mg/100 ml) to 140+/-5%, chlorpropamide (8.3 mg/100 ml) to 139+/-6%, and tolazamide (3.1 mg/100 ml) to 119+/-6%. These effects were accentuated in the presence of 2.5 x 10(-4) M theophylline and were not blocked by 1 x 10(-5) M propranolol. Adenyl cyclase was activated by each of these drugs at concentrations below those which increase contractility. The drugs also increased the rate and slope of phase 4 depolarization in spontaneously beating Purkinje fibers, but did not alter the spontaneous rate of isolated rabbit atria. Since inotropic and chronotropic stimulation can be deleterious in some clinical settings, these findings may be of significance in interpretation of cardiovascular mortality data.
长期临床研究表明,甲苯磺丁脲治疗与心血管死亡发生率增加有关。研究了该药及其他磺酰脲类药物对离体兔心房收缩性和速率、离体犬浦肯野纤维自律性以及兔和人心脏微粒体制剂中腺苷酸环化酶活性的影响。在临床可达到的浓度下,甲苯磺丁脲(10毫克/100毫升)使驱动的兔心房收缩性增加至对照的124±5%,醋磺己脲(3.9毫克/100毫升)至140±5%,氯磺丙脲(8.3毫克/100毫升)至139±6%,妥拉磺脲(3.1毫克/100毫升)至119±6%。在2.5×10⁻⁴M茶碱存在下,这些作用增强,且不被1×10⁻⁵M普萘洛尔阻断。这些药物在低于增加收缩性的浓度时即可激活腺苷酸环化酶。这些药物还增加了自发搏动的浦肯野纤维4期去极化的速率和斜率,但未改变离体兔心房的自发速率。由于在某些临床情况下,变力性和变时性刺激可能有害,这些发现对于解释心血管死亡率数据可能具有重要意义。